MARKET

OGEN

OGEN

Oragenics
AMEX
0.4878
-0.0152
-3.02%
After Hours: 0.4829 -0.0049 -1.00% 19:34 09/25 EDT
OPEN
0.5200
PREV CLOSE
0.5030
HIGH
0.5200
LOW
0.4826
VOLUME
13.35K
TURNOVER
--
52 WEEK HIGH
1.450
52 WEEK LOW
0.4753
MARKET CAP
2.20M
P/E (TTM)
-0.1360
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OGEN last week (0914-0918)?
Weekly Report · 6d ago
Oragenics Highlights Nasal Innovation at Industry Forum
TipRanks · 09/16 15:00
Weekly Report: what happened at OGEN last week (0907-0911)?
Weekly Report · 09/14 09:53
Weekly Report: what happened at OGEN last week (0831-0904)?
Weekly Report · 09/07 09:49
Weekly Report: what happened at OGEN last week (0824-0828)?
Weekly Report · 08/31 09:54
Oragenics Faces NYSE Compliance Challenges Amid Trial Progress
TipRanks · 08/28 21:36
*Oragenics: Received Responses From FDA Related to Its Type B Meeting Request Briefing Package, Submitted in July >OGEN
Dow Jones · 08/28 20:31
*Oragenics: Remains Focused on Execution Across Clinical, Regulatory, Corporate Objectives >OGEN
Dow Jones · 08/28 20:31
More
About OGEN
Oragenics, Inc. is a development-stage company. It is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. It focuses on nasal delivery of pharmaceutical medications in neurology and fighting infectious diseases, including drug candidates for treating mild traumatic brain injury (mTBI or Concussion), and for treating Niemann Pick Disease Type C (NPC), and proprietary powder formulation and an intranasal delivery device. Its lead product, ONP-002, is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. It is also focused on developing medical products that treat brain related illnesses and diseases (the Neurology Assets). Its other product candidate, ONP-001, is in its early stage and clinical trials.

Webull offers Oragenics Inc stock information, including AMEX: OGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OGEN stock methods without spending real money on the virtual paper trading platform.